Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nitrogen is a colorless, odorless diatomic gas (N2) that serves as a medical gas and a cryogen. In clinical trials, particularly those evaluating inhaled nitric oxide for conditions like acute kidney injury (AKI) following cardiac surgery, nitrogen is used as a blinded control gas to ensure consistent ventilation parameters without the active pharmacological effects of the treatment gas. In its liquid form, nitrogen is used as a cryogen in cryoablation systems (e.g., IceCure Medical's ProSense) to treat malignant and benign tumors in the breast, lung, kidney, and liver by inducing thermal destruction of tissue. It is also used topically in dermatology for superficial cryotherapy to treat conditions like alopecia areata by improving microcirculation through reactive vasodilation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nitrogen.